文献速递神经乳腺MR

高风险乳腺癌女性筛查乳腺MRI暴露于钆特酸葡甲胺后3.0-T脑部信号评估

Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
PubMed 文献 · Radiology · 2019-10-22

前瞻性研究纳入25例因高风险乳腺癌筛查而暴露于钆特酸葡甲胺的健康女性(平均累积剂量129 mL)与16例从未暴露者,行3.0-T脑MRI T1 mapping和MPRAGE序列。幕下区累积剂量与T1值或信号强度比值无相关性;以年龄为混杂因素行偏相关分析,苍白球与内囊前脚比值与剂量呈中度负相关(r=-0.40,P=.01),而苍白球T1值无相关性(r=0.19,P=.24)。结论为接受较大累积剂量后深部脑核团未见T1信号增高。

要点

  • 高风险乳腺癌年筛乳腺MRI者接受钆特酸葡甲胺后,深部脑核团未见T1信号增高。
  • 幕下区累积剂量与T1值(P=.66)及信号强度比值(P=.55)均无相关性。
  • 年龄校正后苍白球与内囊前脚比值与剂量呈中度负相关(r=-0.40,P=.01)。

核心结论

  • 健康高风险乳腺癌女性接受相对较大累积剂量的钆特酸葡甲胺后,3.0-T MRI深部脑核团未见T1信号增高。

研究设计与样本

  • 前瞻性研究,2017年11月至2018年3月,纳入暴露组25例(平均年龄51岁±11)和未暴露组16例(平均年龄37岁±10)。
  • 暴露组因高风险乳腺癌筛查接受钆特酸葡甲胺,平均累积剂量129 mL(中位数112 mL;范围70-302 mL);未暴露组从未接受任何钆基对比剂。
  • 采用3.0-T脑MRI专用头线圈,包括T1 mapping和磁化准备快速梯度回波序列。
  • 测量齿状核、苍白球、内囊前脚和脑桥的T1时间及T1信号强度,计算齿状核与脑桥、苍白球与内囊前脚比值。
  • 统计分析包括单变量Pearson相关系数和多变量偏回归分析。

关键影像表现/征象

  • 幕下区未检测到累积钆基对比剂剂量与T1时间或信号强度比值之间的相关性(分别为P=.66和P=.55)。
  • 以年龄为混杂因素的偏相关分析显示,苍白球与内囊前脚比值与钆基对比剂剂量呈中度负相关(r=-0.40;P=.01)。
  • 苍白球T1时间与钆基对比剂剂量无相关性(r=0.19;P=.24)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Otherwise healthy women at high risk for breast cancer undergo annual contrast agent-enhanced breast MRI screening examinations, resulting in high cumulative doses of gadolinium-based contrast agents (GBCAs). Whereas the majority of studies showed no T1 signal ratio increase in deep brain nuclei after more than six doses of macrocyclic GBCA, this has not been explored in a healthy study population. Purpose To assess whether women who are administered large cumulative doses of macrocyclic GBCA with breast MRI at high-risk breast cancer screening exhibit T1 alterations in deep brain nuclei. Materials and Methods In this prospective study from November 2017 to March 2018, healthy women who were either exposed (because of high-risk breast cancer screening) or unexposed to only gadoterate meglumine underwent 3.0-T brain MRI with a dedicated head coil, including T1 mapping and magnetization-prepared rapid gradient-echo sequences. T1 times and T1 signal intensities were measured in the dentate nucleus (DN), globus pallidus (GP), crus anterior of capsula interna (CA), and pons. Ratios of DN to pons and GP to CA were calculated, and univariable Pearson correlation coefficients were calculated. Multivariable analysis included partial regression analysis. Results This study evaluated 25 women (mean age, 51 years ± 11 [standard deviation]) who were exposed to a mean GBCA dose of 129 mL (median 112 mL; range, 70-302 mL) and 16 women (mean age, 37 years ± 10) who were never exposed to any GBCA. Infratentorially, no correlation between cumulative GBCA dose and T1 times or signal intensity ratios was detected (P = .66 and .55, respectively). In partial correlation analysis by considering age as a confounder, there was a moderate negative correlation between GP-to-CA ratio and GBCA dose (r = -0.40; P = .01) but not for GP T1 times (r = 0.19; P = .24). Conclusion After administration of relatively large cumulative doses of gadoterate dimeglumine, healthy women at high risk for breast cancer who underwent annual contrast-enhanced breast MRI screening did not exhibit T1 signal increase in deep brain nuclei at 3.0-T MRI. © RSNA, 2019.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Bennani-Baiti B, Krug B, Giese D, et al. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI. Radiology. 2019. PMID: 31638488. doi:10.1148/radiol.2019190847

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。